0001576427-18-000092.txt : 20181113
0001576427-18-000092.hdr.sgml : 20181113
20181113172944
ACCESSION NUMBER: 0001576427-18-000092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181108
FILED AS OF DATE: 20181113
DATE AS OF CHANGE: 20181113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mesrobian Edmond
CENTRAL INDEX KEY: 0001639494
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36153
FILM NUMBER: 181179327
MAIL ADDRESS:
STREET 1: 10 S ALMADEN BLVD
STREET 2: 16TH FLOOR
CITY: SAN JOSE
STATE: CA
ZIP: 95113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Criteo S.A.
CENTRAL INDEX KEY: 0001576427
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311]
IRS NUMBER: 000000000
STATE OF INCORPORATION: I0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 RUE BLANCHE
CITY: PARIS
STATE: I0
ZIP: 75009
BUSINESS PHONE: 33140402290
MAIL ADDRESS:
STREET 1: 32 RUE BLANCHE
CITY: PARIS
STATE: I0
ZIP: 75009
4
1
wf-form4_154214816687301.xml
FORM 4
X0306
4
2018-11-08
0
0001576427
Criteo S.A.
CRTO
0001639494
Mesrobian Edmond
C/O CRITEO LEGAL DEPT.
387 PARK AVENUE SOUTH, 12TH FLOOR
NEW YORK
NY
10016
1
0
0
0
Non-employee Warrant (right to buy)
22.45
2018-11-08
4
A
0
25000
7.87
A
2028-10-25
Ordinary Shares
25000.0
25000
D
The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants.
One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director.
/s/ Ryan Damon, as attorney-in-fact for Edmond Mesrobian
2018-11-13